Quarterly Results (Unaudited) - Schedule of Quarterly Financial Information (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

12 Months Ended

Dec. 31, 2020

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Dec. 31, 2019

Sep. 30, 2019

Jun. 30, 2019

Mar. 31, 2019

Dec. 31, 2020

Dec. 31, 2019

Dec. 31, 2018

Quarterly Financial Information Disclosure [Abstract]

Revenues

$ 761

$ 756

$ 335

$ 1,001

$ 1,495

$ 764

$ 1,903

$ 1,899

$ 2,853

$ 6,061

$ 10,060

Net loss attributable to common limited partners and the general partner’s interests

(456)

^[1]

(808)

^[1]

(1,542)

^[1]

(4,831)

^[1]

(12,286)

^[2]

(1,547)

^[2]

(839)

^[2]

(868)

^[2]

Allocation of net income (loss) attributable to common limited partners and the general partner:

Common limited partners’ interest

(447)

(792)

(1,511)

(4,735)

(12,040)

(1,516)

(823)

(851)

(7,485)

(15,230)

(44,108)

General partner’s interest

$ (9)

$ (16)

$ (31)

$ (96)

$ (246)

$ (31)

$ (16)

$ (17)

$ (152)

$ (310)

(900)

Basic

$ (0.02)

$ (0.03)

$ (0.06)

$ (0.20)

$ (0.50)

$ (0.07)

$ (0.04)

Diluted

$ (0.02)

$ (0.03)

$ (0.06)

$ (0.20)

$ (0.50)

$ (0.07)

$ (0.04)

Antidilutive securities excluded from computation of diluted earnings attributable to common limited partners outstanding units

2,330,000

All antidilutive securities excluded from computation of diluted earnings attributable to common limited partners outstanding units

For each of the first, second, third and fourth quarters of the year ended December 31, 2020, approximately 2,330,000 common limited partner warrants were excluded from the computation of diluted earnings attributable to common limited partners per unit, because the inclusion of units issuable upon the exercise of the warrants would have been anti-dilutive

For each of the first, second, and fourth quarters of the year ended December 31, 2019, approximately 2,330,000 common limited partner warrants were excluded from the computation of diluted earnings attributable to common limited partners per unit, because the inclusion of units issuable upon the exercise of the warrants would have been anti-dilutive.

Common limited partners’ interest

$ (447)

$ (792)

$ (1,511)

$ (4,735)

$ (12,040)

$ (1,516)

$ (823)

$ (851)

$ (7,485)

$ (15,230)

(44,108)

General partner’s interest

$ (9)

$ (16)

$ (31)

$ (96)

$ (246)

$ (31)

$ (16)

$ (17)

$ (152)

$ (310)

$ (900)

Basic

$ (0.02)

$ (0.03)

$ (0.06)

$ (0.20)

$ (0.50)

$ (0.07)

$ (0.04)

Diluted

$ (0.02)

$ (0.03)

$ (0.06)

$ (0.20)

$ (0.50)

$ (0.07)

$ (0.04)

[1]	For each of the first, second, third and fourth quarters of the year ended December 31, 2020, approximately 2,330,000 common limited partner warrants were excluded from the computation of diluted earnings attributable to common limited partners per unit, because the inclusion of units issuable upon the exercise of the warrants would have been anti-dilutive.
[2]	For each of the first, second, and fourth quarters of the year ended December 31, 2019, approximately 2,330,000 common limited partner warrants were excluded from the computation of diluted earnings attributable to common limited partners per unit, because the inclusion of units issuable upon the exercise of the warrants would have been anti-dilutive.

Atlas Growth Partners, L.P. 10-K